[Electrical cardioversion in pregnancy - case report]

Area of Science:

• Cardiology
• Obstetrics and Gynecology
• Maternal-Fetal Medicine

Background:

• Supraventricular tachycardia (SVT) poses risks during pregnancy, especially in patients with pre-existing heart conditions.
• Management of SVT in pregnancy requires careful consideration of maternal and fetal well-being.

Purpose of the Study:

• To describe the management and outcomes of SVT during pregnancy.
• To highlight the safety and efficacy of electrical cardioversion in this specific patient population.

Main Methods:

• A case report detailing the management of a pregnant patient with a history of complex congenital heart defect and SVT.
• Electrical cardioversion was performed at 30 weeks gestation under continuous fetal monitoring.
• The patient had a pacemaker due to sinoatrial (SA) and atrioventricular (AV) node dysfunction.

Main Results:

• Electrical cardioversion was successfully performed without immediate complications.
• The remainder of the pregnancy was uneventful.
• Delivery via cesarean section at 37+3/7 weeks due to obstetric indications (breech presentation, premature rupture of membranes) was without complications.

Conclusions:

• Electrical cardioversion is a viable and safe treatment option for supraventricular tachycardia during pregnancy, even in patients with complex cardiac histories.
• Close maternal and fetal monitoring is crucial during and after the procedure.
• Successful perinatal outcomes are achievable with appropriate management.